189 related articles for article (PubMed ID: 8557981)
1. Analysis of antigen binding and idiotypic expression by antibodies with polyglycine-replaced complementarity-determining regions.
Sompuram SR; Den W; Sharon J
J Immunol; 1996 Feb; 156(3):1071-81. PubMed ID: 8557981
[TBL] [Abstract][Full Text] [Related]
2. Analysis of BR96 binding sites for antigen and anti-idiotype by codon-based scanning mutagenesis.
Rosok MJ; Eghtedarzadeh-Kondri M; Young K; Bajorath J; Glaser S; Yelton D
J Immunol; 1998 Mar; 160(5):2353-9. PubMed ID: 9498776
[TBL] [Abstract][Full Text] [Related]
3. Somatic mutation in VH complementarity-determining region 2 and framework region 2: differential effects on antigen binding and Ig secretion.
Wiens GD; Heldwein KA; Stenzel-Poore MP; Rittenberg MB
J Immunol; 1997 Aug; 159(3):1293-302. PubMed ID: 9233625
[TBL] [Abstract][Full Text] [Related]
4. Tolerance of single, but not multiple, amino acid replacements in antibody VH CDR 2: a means of minimizing B cell wastage from somatic hypermutation?
Brown M; Rittenburg MB; Chen C; Roberts VA
J Immunol; 1996 May; 156(9):3285-91. PubMed ID: 8617951
[TBL] [Abstract][Full Text] [Related]
5. The critical role of arginine residues in the binding of human monoclonal antibodies to cardiolipin.
Giles I; Lambrianides N; Latchman D; Chen P; Chukwuocha R; Isenberg D; Rahman A
Arthritis Res Ther; 2005; 7(1):R47-56. PubMed ID: 15642142
[TBL] [Abstract][Full Text] [Related]
6. Contribution of heavy chain junctional amino acid diversity to antibody affinity among p-azophenylarsonate-specific antibodies.
Parhami-Seren B; Margolies MN
J Immunol; 1996 Sep; 157(5):2066-72. PubMed ID: 8757328
[TBL] [Abstract][Full Text] [Related]
7. Molecular modeling of an anti-DNA autoantibody (V-88) and mapping of its V region epitopes recognized by heterologous and autoimmune antibodies.
Hobby P; Ward FJ; Denbury AN; Williams DG; Staines NA; Sutton BJ
J Immunol; 1998 Sep; 161(6):2944-52. PubMed ID: 9743357
[TBL] [Abstract][Full Text] [Related]
8. Structural characterization of idiotopes by using antibody variants generated by site-directed mutagenesis.
Sharon J
J Immunol; 1990 Jun; 144(12):4863-9. PubMed ID: 2351832
[TBL] [Abstract][Full Text] [Related]
9. Staphylococcal protein A simultaneously interacts with framework region 1, complementarity-determining region 2, and framework region 3 on human VH3-encoded Igs.
Potter KN; Li Y; Capra JD
J Immunol; 1996 Oct; 157(7):2982-8. PubMed ID: 8816406
[TBL] [Abstract][Full Text] [Related]
10. Display of somatostatin-related peptides in the complementarity determining regions of an antibody light chain.
Simon PJ; Brogle KC; Wang B; Kyle DJ; Soltis DA
Arch Biochem Biophys; 2005 Aug; 440(2):148-57. PubMed ID: 16051181
[TBL] [Abstract][Full Text] [Related]
11. Structural requirements for a specificity switch and for maintenance of affinity using mutational analysis of a phage-displayed anti-arsonate antibody of Fab heavy chain first complementarity-determining region.
Wong YW; Gill DS; Parhami-Seren B; Short MK; Sompuram SR; Margolies MN
J Immunol; 1998 Jun; 160(12):5990-7. PubMed ID: 9637513
[TBL] [Abstract][Full Text] [Related]
12. A single engineered amino acid substitution changes antibody fine specificity.
Kussie PH; Parhami-Seren B; Wysocki LJ; Margolies MN
J Immunol; 1994 Jan; 152(1):146-52. PubMed ID: 8254187
[TBL] [Abstract][Full Text] [Related]
13. Fine mapping of the antigen-antibody interaction of scFv215, a recombinant antibody inhibiting RNA polymerase II from Drosophila melanogaster.
Liu Z; Song D; Kramer A; Martin AC; Dandekar T; Schneider-Mergener J; Bautz EK; Dübel S
J Mol Recognit; 1999; 12(2):103-11. PubMed ID: 10398401
[TBL] [Abstract][Full Text] [Related]
14. Mutational analysis of a sequence-specific ssDNA binding lupus autoantibody.
Cleary J; Glick GD
Biochemistry; 2003 Jan; 42(1):30-41. PubMed ID: 12515537
[TBL] [Abstract][Full Text] [Related]
15. HLA (A*0201) mimicry by anti-idiotypic monoclonal antibodies.
Burlingham WJ; Jankowska-Gan E; DeVito-Haynes L; Fechner JH; Hogan KT; Claas FH; Mulder A; Wang X; Ferrone S
J Immunol; 1998 Dec; 161(12):6705-14. PubMed ID: 9862700
[TBL] [Abstract][Full Text] [Related]
16. A single amino acid mutation in CDR3 of the 3-14-9 L chain abolished expression of the IDA 10-defined idiotope and antigen binding.
Hall BL; Zaghouani H; Daian C; Bona CA
J Immunol; 1992 Sep; 149(5):1605-12. PubMed ID: 1380535
[TBL] [Abstract][Full Text] [Related]
17. Systematic classification of CDR-L3 in antibodies: implications of the light chain subtypes and the VL-VH interface.
Kuroda D; Shirai H; Kobori M; Nakamura H
Proteins; 2009 Apr; 75(1):139-46. PubMed ID: 18798566
[TBL] [Abstract][Full Text] [Related]
18. Functional mapping of conserved residues located at the VL and VH domain interface of a Fab.
Chatellier J; Van Regenmortel MH; Vernet T; Altschuh D
J Mol Biol; 1996 Nov; 264(1):1-6. PubMed ID: 8950262
[TBL] [Abstract][Full Text] [Related]
19. Catalytic antibody model and mutagenesis implicate arginine in transition-state stabilization.
Roberts VA; Stewart J; Benkovic SJ; Getzoff ED
J Mol Biol; 1994 Jan; 235(3):1098-116. PubMed ID: 8289310
[TBL] [Abstract][Full Text] [Related]
20. DNA binding by the VH domain of anti-Z-DNA antibody and its modulation by association of the VL domain.
Chen Y; Stollar BD
J Immunol; 1999 Apr; 162(8):4663-70. PubMed ID: 10202006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]